United Kingdom

Mrinalini Krothapalli

Biogen's revenue misses as Spinraza sales disappoint

24 Apr 2018

Drugmaker Biogen Inc's quarterly revenue missed analysts' estimates on Tuesday as it had disappointing sales of its promising drug Spinraza to treat spinal muscular atrophy because fewer new patients used the expensive treatment.

World News